AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Song, HW Hanlon, N Brown, NR Noble, MEM Johnson, LN Barford, D
Citation: Hw. Song et al., Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with PhosphoCDK2, MOL CELL, 7(3), 2001, pp. 615-626

Authors: Lawrie, AM Tito, P Hernandez, H Brown, NR Robinson, CV Endicott, JA Noble, MEM Johnson, LN
Citation: Am. Lawrie et al., Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells, PROT EX PUR, 23(2), 2001, pp. 252-260

Authors: Davies, TG Tunnah, P Meijer, L Marko, D Eisenbrand, G Endicott, JA Noble, MEM
Citation: Tg. Davies et al., Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate, STRUCTURE, 9(5), 2001, pp. 389-397

Authors: Arold, ST Ulmer, TS Mulhern, TD Werner, JM Ladbury, JE Campbell, ID Noble, MEM
Citation: St. Arold et al., The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases, J BIOL CHEM, 276(20), 2001, pp. 17199-17205

Authors: Sinclair, JC Sandy, J Delgoda, R Sim, E Noble, MEM
Citation: Jc. Sinclair et al., Structure of arylamine N-acetyltransferase reveals a catalytic triad, NAT ST BIOL, 7(7), 2000, pp. 560-564

Authors: Arris, CE Boyle, FT Calvert, AH Curtin, NJ Endicott, JA Garman, EF Gibson, AE Golding, BT Grant, S Griffin, RJ Jewsbury, P Johnson, LN Lawrie, AM Newell, DR Noble, MEM Sausville, EA Schultz, R Yu, W
Citation: Ce. Arris et al., Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles, J MED CHEM, 43(15), 2000, pp. 2797-2804

Authors: Brown, NR Noble, MEM Endicott, JA Johnson, LN
Citation: Nr. Brown et al., The structural basis for specificity of substrate and recruitment peptidesfor cyclin-dependent kinases, NAT CELL BI, 1(7), 1999, pp. 438-443

Authors: Endicott, JA Noble, MEM Tucker, JA
Citation: Ja. Endicott et al., Cyclin-dependent kinases: inhibition and substrate recognition, CURR OP STR, 9(6), 1999, pp. 738-744

Authors: Johnson, LN Noble, MEM Barford, D Brown, N Endicott, JA Lawrie, A Owen, DJ
Citation: Ln. Johnson et al., Signal transduction proteins: Structural basis of control by phosphorylation, J CHEM S P, 21(3), 1999, pp. 185-201

Authors: Noble, MEM Endicott, JA
Citation: Mem. Noble et Ja. Endicott, Chemical inhibitors of cyclin-dependent kinases: Insights into design fromX-ray crystallographic studies, PHARM THERA, 82(2-3), 1999, pp. 269-278

Authors: Owen, DJ Vallis, Y Noble, MEM Hunter, JB Dafforn, TR Evans, PR McMahon, HT
Citation: Dj. Owen et al., A structural explanation for the binding of multiple ligands by the alpha-adaptin appendage domain, CELL, 97(6), 1999, pp. 805-815

Authors: Brown, NR Noble, MEM Lawrie, AM Morris, MC Tunnah, P Divita, G Johnson, LN Endicott, JA
Citation: Nr. Brown et al., Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity, J BIOL CHEM, 274(13), 1999, pp. 8746-8756

Authors: Skamnaki, VT Owen, DJ Noble, MEM Lowe, ED Lowe, G Oikonomakos, NG Johnson, LN
Citation: Vt. Skamnaki et al., Catalytic mechanism of phosphorylase kinase probed by mutational studies, BIOCHEM, 38(44), 1999, pp. 14718-14730
Risultati: 1-13 |